Thermo Fisher Scientific Inc.
TMO Healthcare Diagnostics & Research
Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS grew 9.35%, free cash flow grew 51.8% and total debt rose 18.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow TMO
Thermo Fisher Scientific Inc. (TMO) Revenue growth
Thermo Fisher Scientific Inc.'s revenue growth over the twelve months to 30 June 2026 was 7.23%, up 3.3 percentage points from fiscal 2025 (3.91%). Over the past ten years it has ranged from −4.58% (fiscal 2023) to 26.1% (fiscal 2020); the current reading is higher than 36% of that period. That is below the Diagnostics & Research industry median of 7.69% and below the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 3.91% | 3.86 |
| FY2024 | 0.05% | 4.63 |
| FY2023 | −4.58% | (19.13) |
| FY2022 | 14.6% | (7.16) |
| FY2021 | 21.7% | (4.43) |
| FY2020 | 26.1% | 21.28 |
| FY2019 | 4.86% | (11.59) |
| FY2018 | 16.5% | 1.98 |
| FY2017 | 14.5% | 6.75 |
| FY2016 | 7.72% | 7.27 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 10.5% | 4.31 |
| Mar 2026 | 6.18% | (1.02) |
| Dec 2025 | 7.20% | 2.26 |
| Sep 2025 | 4.94% | 1.96 |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| WAT Waters Corporation compare | 52.5% |
| NTRA Natera, Inc. compare | 37.8% |
| IDXX IDEXX Laboratories, Inc. compare | 12.8% |
| A Agilent Technologies, Inc. compare | 8.60% |
| IQV IQVIA Holdings Inc. compare | 8.17% |
| TMO Thermo Fisher Scientific Inc. | 7.23% |
| MTD Mettler-Toledo International, Inc. compare | 6.91% |
| ILMN Illumina, Inc. compare | 4.88% |
| DHR Danaher Corporation compare | 4.56% |
| Diagnostics & Research industry median | 7.69% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on TMO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement